This presentation summarizes the performance of PharmaSim Team 6 from rounds 5-8 of the simulation. Key points include an overview of their increasing sales, net income, and market share over the rounds. Successes are noted such as a price increase for their Allround drug. Setbacks include not further increasing Allround's price and not launching an additional drug sooner. The presentation concludes with recommendations from Ethik, such as additional price increases and adjusting their sales force and advertising budgets, as well as lessons learned like taking risks and accounting for inflation.